Tag: Prescription Drugs
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
Addition of Immunomodulators Cuts Vascular Inflammation in RA
Significant reduction in disease activity seen for patients receiving TNFi or triple therapy, with no difference between them
Fewer Buprenorphine Initiation Episodes Seen During Pandemic
Number of active buprenorphine episodes comparable to expected number, with fewer initiations and fewer ending of episodes
Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality
Recommendations Updated for Treatment, Prevention of HIV
Because people with HIV are living longer, management of comorbidities throughout the life span is increasingly important
Paxlovid Safe for Pregnant Patients With COVID-19
However, unexpectedly high rate of cesarean deliveries seen in this cohort
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin
Paxlovid Soon Will Not Be Free for Americans
At this point, about 6 million Americans have taken free Paxlovid doses
Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
Individuals who were independently aware of the FDA decision demonstrated reduced willingness to participate
Bromocriptine Quick Release Beneficial for Teens With T1DM
Improvements seen in blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in teens with type 1 diabetes